# Rocket Pharmaceuticals, Inc. (RCKT)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RCKT/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ 75.62M | $ -85.11M | $ 24.80M | $ 368.83M |
| 2025 | $ 0 | $ -228.46M | $ -195.03M | $ 24.88M | $ 277.22M |
| 2024 | $ 0 | $ -271.96M | $ -226.67M | $ 25.50M | $ 463.23M |
| 2023 | $ 0 | $ -265.55M | $ -228.64M | $ 25.04M | $ 492.57M |
| 2022 | $ 0 | $ -247.84M | $ -208.72M | $ 22.87M | $ 489.69M |
| 2021 | $ 0 | $ -200.96M | $ -155.15M | $ 22.60M | $ 454.72M |
| 2020 | $ 0 | $ -177.97M | $ -132.11M | $ 61.70M | $ 503.52M |
| 2019 | $ 0 | $ -99.74M | $ -113.50M | $ 47.45M | $ 307.30M |
| 2018 | $ 0 | $ -98.42M | $ -72.96M | $ 41.45M | $ 194.04M |
| 2017 | $ 0 | $ -39.74M | $ -35.27M | $ 49.54M | $ 47.76M |
| 2016 | $ 0 | $ -58.96M | $ -51.94M | $ 48.96M | $ 73.17M |
| 2015 | $ 0 | $ -95.45M | $ -25.03M | $ 0 | $ 108.81M |
| 2014 | $ 0 | $ -13.47M | $ -13.77M | $ 7.15M | $ -51.56M |
| 2013 | $ 0 | $ -2.80M | $ -2.53M | $ 6.81M | $ -38.90M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.07 |
| Liabilities / Eq | 0.15 |
| Current Ratio | 9.24 |

## Other views

- [Metrics](https://sponda.capital/en/RCKT.md)
- [Charts](https://sponda.capital/en/RCKT/charts.md)
- [Compare](https://sponda.capital/en/RCKT/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.